Used in research and diagnostic applications to detect, quantify, or neutralize the chemokine CXCL8 (also known as IL-8), this antibody plays a key role in studies involving inflammation, immune response, and cancer. It is commonly employed in assays such as ELISA, Western blotting, flow cytometry, and immunohistochemistry to measure IL-8 levels in biological samples. Due to IL-8's involvement in recruiting immune cells to sites of inflammation, this antibody is valuable in investigating chronic inflammatory diseases like rheumatoid arthritis, asthma, and inflammatory bowel disease. It is also used in cancer research, as elevated IL-8 is associated with tumor progression, angiogenesis, and metastasis in various cancers including melanoma and prostate cancer. In therapeutic development, it serves as a reference tool for evaluating the efficacy of drugs targeting the IL-8 pathway.